Drug Manufacturing License On-site Audit from NMPA
Date：2020-12-24In Dec 2020, we got the Drug Manufacturing License on-site audit from NMPA, including Rifaximin, Rifabutin, Rifamycin sodium, Pas sodium.
In Dec 2020, we got the Drug Manufacturing License on-site audit from NMPA, including Rifaximin, Rifabutin, Rifamycin sodium, Pas sodium.